elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33495209-E3DB2C4C-AEDA-4F18-89FD-C71E191A0708
Q33495209-E3DB2C4C-AEDA-4F18-89FD-C71E191A0708
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33495209-E3DB2C4C-AEDA-4F18-89FD-C71E191A0708
Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials Group.
P2860
Q33495209-E3DB2C4C-AEDA-4F18-89FD-C71E191A0708
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33495209-E3DB2C4C-AEDA-4F18-89FD-C71E191A0708
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
041a8c579ed3fe0c193861c0de67f8a303a80451
P2860
[Assessment of antitumor activity rhizoxin for human lung cancer cell lines: a potent new drug for drug-resistant lung cancer].